Hiru Corporation
PINK SHEETS : HIRU

Hiru Corporation

March 08, 2011 15:46 ET

Shaungshi AHP (HIRU): Further Development in Company's R&D

HENDERSON, NEVADA--(Marketwire - March 8, 2011) - Hiru Corporation (PINK SHEETS:HIRU) (www.hirucorporation.com) following the news from March 1, 2011 subsidiary Jiangxi Shaungshi AHP has announced that two additional company's veterinary products have passed Chinese government testing.

Jiangxi Shaungshi AHP received a report from the Chinese Ministry of Agriculture with notification that the two products Shaungshi AHP had submitted for testing passed inspection and have obtained approval documents, stating that they meet mandatory GB Standards. These Chinese national standards are issued by the Standardization Administration of China (SAC), the Chinese National Committee of the ISO and IEC (International Electrotechnical Commission).

The two approved veterinary products are:

  • Sulfadiazine Sodium Injection (Veterinary Drug # 0704023493)
  • Sulfamonomethoxine Sodium Injection (Veterinary Drug # 070423494)

Jiangxi Shaungshi AHP expects these products to enhance the company's already extensive portfolio. It will start producing and marketing these products to Chinese farmers shortly. The company's research and development center has been hard at work and expects to bring more products into the Chinese market.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hiru Corporation that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project" and similar words and phrases are intended to identify such forward-looking statements. Hiru Corporation cautions you that any forward-looking information provided by or on behalf Hiru Corporation is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hiru Corporation's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hiru Corporation's control. In addition to those discussed in Hiru Corporation's press releases, public filings, and statements by Hiru Corporation's management, including, but not limited to, Hiru Corporation's estimate of the sufficiency of its existing capital resources, Hiru Corporation's ability to raise additional capital to fund future operations, Hiru Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Hiru Corporation's capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hiru Corporation does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

Contact Information